Merck (MRK) Stock Up 1%, UK Regulator Approves Its COVID-19 Pill Molnupiravir
Following the approval of the Molnupiravir Covid-19 pill by the UK medicine regulator, Merck said it is on track to deliver as many as 10 million courses by the end of this year.